Genetic Technologies Limited (GNTLF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.18 Million AUD | -58.36% |
| 2023 | 14.85 Million AUD | -28.58% |
| 2022 | 20.8 Million AUD | -9.45% |
| 2021 | 22.97 Million AUD | 46.94% |
| 2020 | 15.63 Million AUD | 378.8% |
| 2019 | 3.26 Million AUD | -47.05% |
| 2018 | 6.16 Million AUD | -49.08% |
| 2017 | 12.1 Million AUD | -8.89% |
| 2016 | 13.28 Million AUD | -35.86% |
| 2015 | 20.71 Million AUD | 207.91% |
| 2014 | 6.72 Million AUD | -19.12% |
| 2013 | 8.31 Million AUD | -49.4% |
| 2012 | 16.44 Million AUD | 84.28% |
| 2011 | 8.92 Million AUD | 7.76% |
| 2010 | 8.27 Million AUD | -62.83% |
| 2009 | 22.27 Million AUD | -7.75% |
| 2008 | 24.14 Million AUD | 15.25% |
| 2007 | 20.95 Million AUD | -6.64% |
| 2006 | 22.44 Million AUD | -23.31% |
| 2005 | 29.26 Million AUD | 30.71% |
| 2004 | 22.38 Million AUD | -25.97% |
| 2003 | 30.24 Million AUD | -8.35% |
| 2002 | 33 Million AUD | -16.84% |
| 2001 | 39.68 Million AUD | 348.58% |
| 2000 | 8.84 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.46 Million AUD | -43.01% |
| 2024 Q4 | 6.18 Million AUD | 0.0% |
| 2024 FY | 6.18 Million AUD | -58.36% |
| 2024 Q2 | 8.46 Million AUD | 0.0% |
| 2023 FY | 14.85 Million AUD | -28.58% |
| 2023 Q4 | 14.85 Million AUD | 0.0% |
| 2023 Q3 | 14.85 Million AUD | -5.34% |
| 2023 Q1 | 15.69 Million AUD | -24.55% |
| 2023 Q2 | 15.69 Million AUD | 0.0% |
| 2022 FY | 20.8 Million AUD | -9.45% |
| 2022 Q3 | 20.8 Million AUD | -7.72% |
| 2022 Q4 | 20.8 Million AUD | 0.0% |
| 2022 Q2 | 22.54 Million AUD | 0.0% |
| 2022 Q1 | 22.54 Million AUD | -1.87% |
| 2021 Q4 | 22.97 Million AUD | 0.0% |
| 2021 Q2 | 18.84 Million AUD | 0.0% |
| 2021 Q1 | 18.84 Million AUD | 20.54% |
| 2021 FY | 22.97 Million AUD | 46.94% |
| 2021 Q3 | 22.97 Million AUD | 21.91% |
| 2020 Q4 | 15.63 Million AUD | 0.0% |
| 2020 Q1 | 4.34 Million AUD | 33.04% |
| 2020 Q2 | 4.34 Million AUD | 0.0% |
| 2020 Q3 | 15.63 Million AUD | 259.91% |
| 2020 FY | 15.63 Million AUD | 378.8% |
| 2019 FY | 3.26 Million AUD | -47.05% |
| 2019 Q2 | 4.11 Million AUD | 0.0% |
| 2019 Q1 | 4.11 Million AUD | -33.25% |
| 2019 Q3 | 3.26 Million AUD | -20.67% |
| 2019 Q4 | 3.26 Million AUD | 0.0% |
| 2018 Q1 | 8.54 Million AUD | -29.42% |
| 2018 Q4 | 6.16 Million AUD | 0.0% |
| 2018 Q3 | 6.16 Million AUD | -27.85% |
| 2018 FY | 6.16 Million AUD | -49.08% |
| 2018 Q2 | 8.54 Million AUD | 0.0% |
| 2017 Q4 | 12.1 Million AUD | 0.0% |
| 2017 Q3 | 12.1 Million AUD | -26.51% |
| 2017 Q2 | 16.47 Million AUD | 0.0% |
| 2017 Q1 | 16.47 Million AUD | 23.97% |
| 2017 FY | 12.1 Million AUD | -8.89% |
| 2016 Q4 | 13.28 Million AUD | 0.0% |
| 2016 Q3 | 13.28 Million AUD | -22.78% |
| 2016 Q2 | 17.21 Million AUD | 0.0% |
| 2016 Q1 | 17.21 Million AUD | -16.93% |
| 2016 FY | 13.28 Million AUD | -35.86% |
| 2015 Q1 | 3.45 Million AUD | -48.71% |
| 2015 Q3 | 20.71 Million AUD | 500.31% |
| 2015 Q2 | 3.45 Million AUD | 0.0% |
| 2015 FY | 20.71 Million AUD | 207.91% |
| 2015 Q4 | 20.71 Million AUD | 0.0% |
| 2014 Q2 | 15.19 Million AUD | 0.0% |
| 2014 Q1 | 15.19 Million AUD | 82.68% |
| 2014 Q4 | 6.72 Million AUD | 0.0% |
| 2014 Q3 | 6.72 Million AUD | -55.72% |
| 2014 FY | 6.72 Million AUD | -19.12% |
| 2013 Q3 | 8.31 Million AUD | -35.31% |
| 2013 FY | 8.31 Million AUD | -49.4% |
| 2013 Q4 | 8.31 Million AUD | 0.0% |
| 2013 Q2 | 12.86 Million AUD | 0.0% |
| 2012 Q2 | 16.14 Million AUD | 0.0% |
| 2012 FY | 16.44 Million AUD | 84.28% |
| 2012 Q4 | 16.44 Million AUD | 0.0% |
| 2011 FY | 8.92 Million AUD | 7.76% |
| 2011 Q4 | 8.92 Million AUD | 0.0% |
| 2011 Q2 | 12.46 Million AUD | 0.0% |
| 2010 Q2 | 12.71 Million AUD | 0.0% |
| 2010 FY | 8.27 Million AUD | -62.83% |
| 2010 Q4 | 8.27 Million AUD | 0.0% |
| 2009 FY | 22.27 Million AUD | -7.75% |
| 2009 Q2 | 22.17 Million AUD | 0.0% |
| 2009 Q4 | 17.97 Million AUD | 0.0% |
| 2008 FY | 24.14 Million AUD | 15.25% |
| 2008 Q2 | 28.51 Million AUD | 0.0% |
| 2008 Q4 | 24.14 Million AUD | 0.0% |
| 2007 FY | 20.95 Million AUD | -6.64% |
| 2007 Q4 | 20.95 Million AUD | 0.0% |
| 2007 Q2 | 29 Million AUD | 0.0% |
| 2006 FY | 22.44 Million AUD | -23.31% |
| 2006 Q4 | 22.44 Million AUD | 0.0% |
| 2006 Q2 | 38.7 Million AUD | 0.0% |
| 2005 Q2 | 21.81 Million AUD | 0.0% |
| 2005 Q4 | 29.26 Million AUD | 0.0% |
| 2005 FY | 29.26 Million AUD | 30.71% |
| 2004 FY | 22.38 Million AUD | -25.97% |
| 2003 FY | 30.24 Million AUD | -8.35% |
| 2002 FY | 33 Million AUD | -16.84% |
| 2001 FY | 39.68 Million AUD | 348.58% |
| 2000 FY | 8.84 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -387.512% |
| Arrayit Corporation | 1 Million USD | -518.412% |
| Atlantic International Corp. | 4.43 Million USD | -39.45% |
| Biocept, Inc. | 30.87 Million USD | 79.961% |
| Bioqual, Inc. | 56.58 Million USD | 89.067% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -2567.386% |
| DermTech, Inc. | 121.93 Million USD | 94.926% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.852% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 65.201% |
| iMD Companies, Inc. | 190.13 Thousand USD | -3153.718% |
| IDenta Corp. | 1.52 Million USD | -304.539% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 52.488% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 25.029% |
| InVitro International | 1.53 Million USD | -303.292% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 76.949% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -267483.088% |
| Medical Imaging Corp. | 4.19 Million USD | -47.592% |
| NovelStem International Corp. | 2.25 Million USD | -174.402% |
| Optigenex Inc. | 1.88 Million USD | -227.626% |
| PharmChem, Inc. | 2.76 Million USD | -123.699% |
| Proteome Sciences plc | 14.58 Million USD | 57.586% |
| Response Genetics, Inc | 48.88 Million USD | 87.344% |
| Rennova Health, Inc. | 20.57 Million USD | 69.929% |
| RushNet, Inc. | 6.04 Million USD | -2.297% |
| ScreenPro Security Inc. | 1.26 Million USD | -390.465% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -1209.53% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -782.966% |
| Todos Medical Ltd. | 15.26 Million USD | 59.478% |